RESULTS (CONTINUED) 
STUDY DESIGN
• A cross-sectional online survey completed by participants in the UK who had undergone surgery because of their UC
SAMPLE AND RECRUITMENT
• Recruitment aimed for a target sample of 200 UK participants diagnosed with UC who had undergone surgery for their UC • Participants were recruited through a specialist patient recruitment agency directly from patient panels (where participants had provided consent to be part of a panel and contacted should they be potentially eligible for study inclusion)
INCLUSION CRITERIA:
• 18+ years of age • Resident in the UK • Able to give informed consent • Received a formal diagnosis of UC • Undergone bowel surgery as a result of their UC (not counting minimal procedures such as colonoscopy and endoscopy)
EXCLUSION CRITERIA:
• A diagnosis of any of the following: -Colorectal or any other cancer, for which they are currently being treated -Stroke -Multiple Sclerosis -Chronic obstructive pulmonary disease -Chronic kidney disease -Diabetes (Type I and Type II)
ASSESSMENTS
• Socio-demographic and disease history • HRQL utility assessment (EQ-5D-5L) • AbbVie sponsored this study and provided financial support, participated in the interpretation of data, writing, review and approval of the abstract and poster • 202 eligible participants completed the survey and were included in the analysis.
• Figure 1 shows participant distribution across age groups
• The majority of the sample were female (n=115, 57%)
• Diversity in sample ethnicity was similar to UK population norms (90% in the sample was white vs. 92% in the UK population) as was active employment levels (72% vs. 73%) 1 • A larger proportion had completed a university degree than may be expected from UK population norms (36% vs. 27%) 1 • Compared to UK population norms a smaller proportion were not in a relationship (22% vs. 52%) 1 • Over 58% of participants were >1 year post-surgery (Table  1) • Although the majority of participants had only 1 surgery due to UC, nearly 10% had ≥4 operations and over a third reported that they had been told they would require further surgery for their UC in the near future • Nearly 60% were experiencing ongoing symptoms at the time of survey completion, which for just over 40% had worsened in the past year
• Increased fatigue, abdominal pain and increased stool frequency were the most common symptoms post-surgery ( Table 2) • A quarter of the sample reported >1 type of symptom since surgery and over a third reported seeing a healthcare professional for these symptoms.
• Forty percent reported taking medication to control their symptoms since UC surgery 
LIMITATIONS
• The study provides a snap-shot of patient experience, without being able to consider patients' pre-surgery levels of HRQL or function • The lack of a matched non-surgical UC comparison or healthy adult control group limits comparison and interpretation of the study results • The results are descriptive in nature and individual-level data contributed to multiple mean sub-group values and comparisons without taking into account shared variance in scores
• A marked decrease in utility by IBDQ disease severity was observed: those classified as having severe disease had lower scores than those classified as being in remission (0.52 vs 0.88) (Figure 2 
Mild ( • Participants with complications also reported more work time missed, greater impairment while working and greater overall impairment of regular activities due to UC than those without complications ( 
